Brief: India's Panacea Biotec Dec-Qtr Consol Net Loss Widens
14/02/2022 10:43
Feb 14 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* DEC-QUARTER CONSOL NET LOSS AFTER TAX 492 MILLION RUPEES
VERSUS
LOSS 400.5 MILLION RUPEES YEAR AGO
* DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.56 BILLION
RUPEES
VERSUS 1.42 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE4pHN0R
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility